Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Monocyte Activation Tests Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising emphasis on patient safety and demand for safe and more reliable pyrogen testing
5.1.1.2. Growing initiatives for animal-based in-vitro alternatives
5.1.1.3. Increasing investments in the pharmaceutical sector by private and public sectors
5.1.2. Restraints
5.1.2.1. Capital intensive development process of MAT kits and reagents
5.1.3. Opportunities
5.1.3.1. Launch of newly developed monocyte activation test kits
5.1.3.2. Rising healthcare infrastructure and spending across economies
5.1.4. Challenges
5.1.4.1. Stringent regulatory hurdles associated with approval of MAT kits and reagents
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Monocyte Activation Tests Market, by Product
6.1. Introduction
6.2. Monocyte Activation Test Kits
6.3. Reagents

7. Monocyte Activation Tests Market, by Source
7.1. Introduction
7.2. Cell Line-based
7.3. PBMC-based

8. Monocyte Activation Tests Market, by Application
8.1. Introduction
8.2. Drug Development
8.3. Medical devices Testing
8.4. Vaccine Development

9. Monocyte Activation Tests Market, by End-user
9.1. Introduction
9.2. Biotechnology Companies
9.3. Medical Device Manufacturers
9.4. Pharmaceutical Manufacturers

10. Americas Monocyte Activation Tests Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Monocyte Activation Tests Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Monocyte Activation Tests Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Becton, Dickinson and Company
14.1.2. CellMade Laboratories
14.1.3. Charles River Laboratories International, Inc
14.1.4. Eurofins Scientific SE
14.1.5. GenScript Biotech Corporation
14.1.6. Lonza Group Ltd.
14.1.7. Lps-Biosciences
14.1.8. MAT BioTech BV
14.1.9. Merck KGaA
14.1.10. Microcoat Biotechnologie GmbH
14.1.11. Nelson Laboratories, LLC by Sotera Health Company
14.1.12. SOLVIAS AG
14.1.13. Thermo Fisher Scientific Inc.
14.1.14. Wickham Micro Limited
14.2. Key Product Portfolio

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing



List of Figures

FIGURE 1. MONOCYTE ACTIVATION TESTS MARKET RESEARCH PROCESS
FIGURE 2. MONOCYTE ACTIVATION TESTS MARKET SIZE, 2022 VS 2030
FIGURE 3. MONOCYTE ACTIVATION TESTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. MONOCYTE ACTIVATION TESTS MARKET DYNAMICS
FIGURE 7. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2022 VS 2030 (%)
FIGURE 10. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 12. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 14. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. MONOCYTE ACTIVATION TESTS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. MONOCYTE ACTIVATION TESTS MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. MONOCYTE ACTIVATION TESTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. MONOCYTE ACTIVATION TESTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY MONOCYTE ACTIVATION TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 9. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY CELL LINE-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PBMC-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY MEDICAL DEVICES TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 16. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 34. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 56. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 60. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 92. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 103. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 105. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 109. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 113. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 129. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 141. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 145. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 149. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 177. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. MONOCYTE ACTIVATION TESTS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 188. MONOCYTE ACTIVATION TESTS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 189. MONOCYTE ACTIVATION TESTS MARKET LICENSE & PRICING